The Pershing Square Sohn Cancer Research Alliance is dedicated to playing a catalytic role in accelerating cures for cancer by enabling the pursuit of the most innovative and advanced cancer research and by facilitating collaborations between science and business.
The Prize for young investigators provides early-stage funding opportunities to New York scientists with innovative ideas in cancer research. The program surrounding the Prize is a catalyst in bridging the gap between the academic scientific community and the business community.
DANIEL BACHOVCHIN, PHD
KIVANC BIRSOY, PHD
ALBERTO CICCIA, PHD
CAMILA DOS SANTOS, PHD
BENJAMIN GREENBAUM, PHD
DAN LANDAU, MD, PHD
BENJAMIN MARTIN, PHD
Cold Spring Harbor, NY — Dr. Bruce Stillman, President and CEO of Cold Spring Harbor Laboratory (CSHL), has been awarded the 2019 Canada Gairdner International Award in honor of his pivotal contributions to basic research. The Canada Gairdner International Award recognizes researchers who have made seminal discoveries or contributions to biomedical science. Dr. Stillman is being honored for “pioneering research on the eukaryotic DNA replication cycles including initiation, regulation, and responses to DNA damage.” The award is shared with Stillman’s collaborator Dr. John Diffley, Associate Director of the Francis Crick Institute and Dr. Stillman’s former postdoctoral fellow.
On Tuesday, October 23rd, 2018, the Pershing Square Sohn Cancer Research Alliance held its Second Annual Pershing Square Sohn Retreat in Nicholls-Biondi Hall at Cold Spring Harbor Laboratory in Long Island. The Retreat gave the 2015 Pershing Square Sohn Prize winners, who had just finished their final year of funding, the chance to present their work performed over the past three years to their peers and mentors.
Bill Ackman, Co-Founder. The Pershing Square Foundation